We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-5.88%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$234M
AUM Growth
-$19.4M
(-7.6%)
Cap. Flow
-$4.73M
Cap. Flow
% of AUM
-2.02%
Top 10 Holdings %
Top 10 Hldgs %
74.74%
Holding
68
New
4
Increased
6
Reduced
6
Closed
20
Top Buys
| 1 |
GSK
GSK
|
+$30M |
| 2 |
Sanofi
SNY
|
+$15.9M |
| 3 |
Cencora
COR
|
+$14.2M |
| 4 |
Smith & Nephew
SNN
|
+$5.85M |
| 5 |
SkinHealth Systems
SKIN
|
+$3.75M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
+$10.4M |
| 2 |
Biogen
BIIB
|
+$7.32M |
| 3 |
Medtronic
MDT
|
+$7.18M |
| 4 |
Sight Sciences
SGHT
|
+$6.52M |
| 5 |
NTUS
Natus Medical Inc
NTUS
|
+$6.26M |
Sector Composition
| 1 | Healthcare | 85.76% |
| 2 | Financials | 9.81% |
| 3 | Consumer Staples | 3.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cencora
COR
$58.8B
| $38.2M | 16.3% |
282,399
+99,065
| +54% | +$14.2M |
|
|
2
GSK
GSK
$103B
| $23.3M | 9.92% |
+790,600
| New | +$30M |
|
|
MSAC
3
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $23M | 9.81% |
2,323,000
| – | – |
|
|
BCYC
4
Bicycle Therapeutics
BCYC
$294M
| $15.9M | 6.78% |
683,425
-5,564
| -0.8% | -$132K |
|
5
Organon & Co
OGN
$3.55B
| $14.7M | 6.28% |
628,836
+53,981
| +9% | +$1.63M |
|
6
Cigna
CI
$80.2B
| $14.6M | 6.23% |
52,611
-423
| -0.8% | -$119K |
|
|
7
Sanofi
SNY
$103B
| $13.6M | 5.79% |
+356,888
| New | +$15.9M |
|
8
Inogen
INGN
$171M
| $12.7M | 5.4% |
521,295
-4,143
| -0.8% | -$114K |
|
9
Centene
CNC
$33.9B
| $9.88M | 4.22% |
127,011
-2,000
| -2% | -$179K |
|
10
United Therapeutics
UTHR
$22.4B
| $9.41M | 4.02% |
44,959
+5,000
| +13% | +$1.12M |
|
|
11
SkinHealth Systems
SKIN
$112M
| $7.77M | 3.31% |
658,964
+296,670
| +82% | +$3.75M |
|
|
12
Smith & Nephew
SNN
$12.6B
| $5.3M | 2.26% |
+228,390
| New | +$5.85M |
|
13
Vanda Pharmaceuticals
VNDA
$352M
| $4.83M | 2.06% |
488,965
| – | – |
|
|
PNT
14
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $4.21M | 1.8% |
544,545
+40,000
| +8% | +$340K |
|
|
NARI
15
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $4.17M | 1.78% |
57,466
-55,000
| -49% | -$4.09M |
|
16
Universal Health Services
UHS
$8.73B
| $3.59M | 1.53% |
40,725
| – | – |
|
|
EUCRU
17
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $2.49M | 1.06% |
248,674
| – | – |
|
18
Orchestra BioMed
OBIO
$221M
| $2.48M | 1.06% |
250,000
| – | – |
|
19
Spyre Therapeutics
SYRE
$8.59B
| $2.46M | 1.05% |
186,741
| – | – |
|
20
X4 Pharmaceuticals
XFOR
$379M
| $2.43M | 1.03% |
47,282
+38,052
| +412% | +$1.31M |
|
21
Modular Medical
MODD
$23.3M
| $2.37M | 1.01% |
19,145
| – | – |
|
|
CBAY
22
DELISTED
Cymabay Therapeutics
CBAY
| $1.95M | 0.83% |
555,610
| – | – |
|
|
RCOR
23
DELISTED
Renovacor, Inc.
RCOR
| $1.85M | 0.79% |
735,908
| – | – |
|
|
MRUS
24
DELISTED
Merus
MRUS
| $1.76M | 0.75% |
87,953
| – | – |
|
|
AFMD
25
DELISTED
Affimed
AFMD
| $1.69M | 0.72% |
82,107
| – | – |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA